Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment..
Hormones (Athens). 17(4), 573-579.
(2018). Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas..
Int J Clin Pract. 65(3), 373-4.
(2011). Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease..
Endocrine. 49(2), 560-2.
(2015). Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease..
Metabolism. 147, 155676.
(2023). Adult hypophosphatasia treated with reduced frequency of teriparatide dosing..
J Musculoskelet Neuronal Interact. 21(4), 584-589.
(2021). Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity..
Hepatobiliary Surg Nutr. 9(1), 73-76.
(2020). Semaglutide, cilofexor, and firsocostat for nonalcoholic steatohepatitis: a dance that may need more than one dancer..
Hormones (Athens).
(2022). Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020). Irisin: A true, circulating hormone..
Metabolism. 64(12), 1611-8.
(2015). Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012). Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?.
Metabolism. 96, iii-v.
(2019). The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease..
Diabetes Obes Metab. 12(5), 365-83.
(2010). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018). Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020). Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease..
Med Hypotheses. 82(6), 795.
(2014).
(2022). Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.
Current Medicinal Chemistry. 30,
(2023). Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment..
Exp Clin Endocrinol Diabetes. 119(9), 519-24.
(2011). Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease..
Exp Clin Endocrinol Diabetes.
(2019). Helicobacter pylori Infection and insulin resistance..
Helicobacter. 18(2), 165-6.
(2013). The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance..
Clinics (Sao Paulo). 66(5), 911-2.
(2011). Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis..
Metabolism. 121, 154818.
(2021). Editorial: adiponectin in health and disease: current evidence and therapeutic perspectives..
Curr Med Chem. 19(32), 5425-6.
(2012). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010). The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease..
Hippokratia. 13(2), 127; author reply 128.
(2009).